Bing Yao, Founder of ArriVent Biopharma

Bing Yao is the founder of ArriVent Biopharma. ArriVent Biopharma has raised $150M in total funding. Latest round: Series A.

About Bing Yao

Bing (Zhengbin) Yao is the CEO and Chairman of the Board at ArriVent Biopharma, a Pennsylvania-based biopharmaceutical company focused on developing furmonertinib for lung cancer. He is described as a biopharma veteran involved in the company's launch and financing.

Bing Yao at a glance

More founder profiles (44)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library